394 POSTER Final results of a Phase I study of cediranib, a VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors
H. Murakami, N. Yamamoto, N. Boku, K. Yamazaki, N. Yamamoto, Y. Yamada, K. Yamada, T. Puchalski, E. Shin, T. TamuraVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72328-0
File:
PDF, 57 KB
english, 2008